Steven Bots

Suggest Changes
Learn More
INTRODUCTION Real-life patterns of anti-tumour necrosis factor (anti-TNF) use remain largely unknown. We aimed to investigate survival rates, clinical outcomes and costs of anti-TNF agents in a large(More)
  • 1